NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT07102394 2026-02-17Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1Johns Hopkins UniversityPhase 1 Recruiting10 enrolled
NCT05957679 2026-02-12MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion AssessmentShengjing HospitalPhase NA Recruiting20 enrolled